Research and Markets has announced the addition of the "Prophylactic Human Vaccines - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Prophylactic Human Vaccines in US$ Million by the following Product Segments: Pediatric Prophylactic Vaccines, and Adult Prophylactic Vaccines.
The report profiles 63 companies including many key and niche players such as
Key Topics Covered:
1. Market Overview & Outlook
2. Market Trends & Issues
3. Competitive Landscape
4. Product Overview
5. Clinical Trials In The Vaccines Market
6. Product Launches/Approvals
7. Recent Industry Activity
8. Focus On Select Players
9. Global Market Perspective
Total Companies Profiled: 63 (including Divisions/Subsidiaries 72)
For more information about this report visit http://www.researchandmarkets.com/research/8dt787/prophylactic
Related Topics: Vaccines
View source version on businesswire.com: http://www.businesswire.com/news/home/20160824005459/en/Business Wire
Last updated on: 24/08/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.